TOKYO, Sept 21 (Reuters) - Pfizer Inc , the world's largest drug maker, said on Friday it is in talks with investors about spinning off its Japanese research and development laboratory, albeit as a ...

Pfizer Inc. will spend $470 million to expand its vaccine research facilities 25 miles northwest of New York City, where the company hopes to maintain its edge in the booming field of messenger RNA, ...

Pfizer said Wednesday that a booster of its COVID-19 vaccine may offer important protection against the new omicron variant even though the initial two doses appear significantly less effective.

NEW YORK - Pfizer said Wednesday that a booster dose of its COVID-19 vaccine may protect against the new omicron variant even though the initial two doses appear significantly less effective. Pfizer ...

A booster dose of the Pfizer-BioNTech vaccine provides protection against omicron that is similar to a two-dose course against the original strain of the coronavirus, the companies said Wednesday ...

An overview of Pfizer within the biopharmaceutical sector, covering research, manufacturing, global distribution, and index ...

The Pfizer-BioNTech Covid-19 vaccine appears to be less effective against the heavily mutated omicron variant of the coronavirus, according to early data from South Africa posted Tuesday. Researchers ...

Pfizer Inc. (NYSE:PFE) is one of the Cheap NYSE Stocks to Buy Now. On December 6, Pfizer Inc. (NYSE: PFE) announced results from its Phase 3 BASIS Study, which evaluates HYMPAVZI for people living ...

(AP) - Pfizer said Wednesday that a booster of its COVID-19 vaccine may offer important protection against the new omicron variant even though the initial two doses appear significantly less effective ...